Thursday, December 19, 2024
HomeTagsNBI-827104

NBI-827104

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-827104 in Pediatric Patients

Neurocrine Biosciences, Inc., a leading neuroscience-focused biopharmaceutical company, today announced that investigational NBI-827104 did not meet its primary endpoint in the Phase 2 STEAMBOATâ„¢...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics